CU disagrees with both FDA’s assertion that genetic engineering itself does not, in and of itself, constitute a “material” difference under the law and also with their definition of what constitutes a “material” difference.
For 85 years CR has worked for laws and policies that put consumers first. Learn more about CR’s work with policymakers, companies, and consumers to help build a fair and just marketplace at TrustCR.org
CU disagrees with both FDA’s assertion that genetic engineering itself does not, in and of itself, constitute a “material” difference under the law and also with their definition of what constitutes a “material” difference.